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Abstract
Background: Increasing pyrethroid resistance has been an undesirable correlate of the rapid increase in coverage
of insecticide-treated nets (ITNs) since 2000. Whilst monitoring of resistance levels has increased markedly over this
period, longitudinal monitoring is still lacking, meaning the temporal and spatial dynamics of phenotypic resistance
in the context of increasing ITN coverage are unclear.
Methods: As part of a large WHO-co-ordinated epidemiological study investigating the impact of resistance on
malaria infection, longitudinal monitoring of phenotypic resistance to pyrethroids was undertaken in 290 clusters
across Benin, Cameroon, India, Kenya and Sudan. Mortality in response to pyrethroids in the major anopheline
vectors in each location was recorded during consecutive years using standard WHO test procedures. Trends in
mosquito mortality were examined using generalised linear mixed-effect models.
Results: Insecticide resistance (using the WHO definition of mortality < 90%) was detected in clusters in all
countries across the study period. The highest mosquito mortality (lowest resistance frequency) was consistently
reported from India, in an area where ITNs had only recently been introduced. Substantial temporal and spatial
variation was evident in mortality measures in all countries. Overall, a trend of decreasing mosquito mortality
(increasing resistance frequency) was recorded (Odds Ratio per year: 0.79 per year (95% CI: 0.79–0.81, P < 0.001).
There was also evidence that higher net usage was associated with lower mosquito mortality in some countries.
Discussion: Pyrethroid resistance increased over the study duration in four out of five countries. Insecticide-based
vector control may be compromised as a result of ever higher resistance frequencies.
Keywords: Malaria, Vector control, Insecticide resistance, Trends, Bednets, Bioassay
Background
Vector control using indoor residual spraying (IRS) and
insecticide-treated nets (ITNs) are core strategies for
malaria control and elimination. The huge scale-up of
these interventions in the last 20 years has been associ-
ated with major reductions in disease burden [1]. Be-
tween 2000 and 2015, it is estimated that over 1 billion
ITNs were distributed in malaria endemic countries.
The proportion of people in sub-Saharan Africa sleeping
under a net increased from 30 to 54% between 2010 and
2016, whilst in 2016 an estimated 2.9% of the at-risk
population was covered by IRS globally [1]. The in-
creased coverage of vector control is estimated to have
been a major contributor to the documented 62% de-
cline in malaria mortality between 2000–2015 [2, 3].
However, between 2015 and 2016, data suggest that mal-
aria mortality have remained the same in the WHO re-
gions of Southeast Asia, the Western Pacific and Africa,
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and possibly increased in the Eastern Mediterranean and
the Americas [1]. There are therefore justified concerns
about the emergence and spread of insecticide resistance
and the impact this may have on the continued effective-
ness of insecticide-based interventions [1, 4].
Resistance has now been detected in malaria vectors to
the four classes of public health insecticides used in mal-
aria vector control (pyrethroids, organochlorines, organo-
phosphates and carbamates) [5], and up to October 2016
had been reported in 71 malaria-endemic countries [6].
Until recently, pyrethroids have been the only class used
for long-lasting insecticidal nets (LLINs) and accounted
for a large proportion of the insecticide used for IRS. This
heavy reliance on a single insecticide class prompted the
World Health Organization (WHO) to issue a Global Plan
for Insecticide Resistance Management (GPIRM) [5]
which was subsequently expanded as part of the Global
Vector Control Response [7]. The aim of these initiatives
is to sustain the advances made in the fight against
vector-borne disease through rational use of vector con-
trol tools, including insecticide deployment to slow the
development of resistance. Country-level implementation
of recommended activities and monitoring has been poor
due to a combination of limited availability and costs of
insecticides with new modes of action; human, financial
and infrastructural capacity shortfalls; and insufficient data
to determine epidemiological impact of insecticide resist-
ance [8]. To address this latter point the WHO, with fund-
ing from the Bill and Melinda Gates Foundation, initiated
a multi-country prospective study to assess the impact of
insecticide resistance on the effectiveness of LLINs and
IRS. The main objectives of the study were: (i) to deter-
mine the impact of insecticide resistance in malaria vec-
tors on the protective effectiveness of LLINs and IRS, and
hence on malaria disease burden; and (ii) to assess trends
in the insecticide resistance status and underlying mecha-
nisms in the main malaria vector species from the study
areas in response to different interventions.
The study was conducted in five countries, Benin,
Cameroon, India, Kenya and Sudan, with data collection
conducted from 2010–2016. Details of the overall study de-
sign are given in Kleinschmidt et al. [9]. Overall epidemio-
logical outcomes, presented in Kleinschmidt et al. [10],
showed that nets provided protection against malaria irre-
spective of resistance frequency, indicating that populations
in malaria endemic areas should continue to use LLINs to
reduce their risk of infection. A number of country-specific
analyses from this and other studies corroborate this find-
ing [11–15]. In addition, several studies have published
country-specific entomological data relating to the second
objective [16–18], with ranges of resistance to pyrethroids
reported. In this paper, we describe temporal and spatial
trends in insecticide resistance of the main malaria vector
species from across the five study countries.
Methods
Study design
The overall study design is described in detail in
Kleinschmidt et al. [9]. The five countries included in
the study were selected to represent areas of varying
transmission intensity where resistance had previously
been detected in malaria vectors (Table 1). In 279 study
clusters (villages or groups of villages) across 16 areas in
the five countries pyrethroid susceptibility in malaria
vectors, and malaria infection and disease in children
were measured simultaneously over several years. We
aimed to assess whether higher levels of resistance are
associated with loss of effectiveness of LLINs, and to
characterise temporal and spatial trends in insecticide
resistance. The numbers of clusters chosen per country
are shown in Table 1 and were based on sample size cal-
culations determined by the epidemiological outcomes
[9]. Clusters were defined as villages or groups of ham-
lets with no less than 500 houses and were at least 2 km
apart to avoid spill over in outcomes between clusters.
Vector control
LLIN mass distributions were carried out routinely in each
site to provide universal coverage for each household (one
net per two persons). Nets were distributed in Benin in
2011 (Olyset Net®, Sumitomo Chemical, Tokyo, Japan; 1 g/
m2 permethrin) and 2014 (PermaNet® 2.0, Vestergaard, Lau-
sanne, Switzerland; 55 mg/m2 deltamethrin), in Cameroon
in 2011 and 2015 (PermaNet® 2.0), in India in 2014 (Perma-
Net® 2.0), in Kenya in 2010 and 2013 (PermaNet® 2.0), and
in Sudan in 2011 and 2014 (PermaNet® 2.0). Net usage, de-
fined as the proportion of respondents reporting as having
slept under an LLIN the previous night, was determined
through cross-sectional surveys which took place at least
once in each country during the study period [10].
Cross-sectional household surveys, which consisted of sam-
pling children from random households occurred in 2012
(Kenya, Sudan), 2013 (Cameroon, Sudan), 2014 (Sudan),
2015 (Benin, India) and 2016 (India) [10]. We used net
usage as a proxy for the level of local mosquito exposure
to pyrethroids. In Sudan half of the clusters were rando-
mised to receive two rounds of IRS with bendiocarb
(Ficam®80% WP, Bayer, Leverkusen, Germany; 200 mg
active ingredient/m2). An exception was the Galabat
region where clusters received IRS with deltamethrin
(25 mg of a.i./m2; Chema Industries, Alexandria, Egypt)
before changing to bendiocarb in subsequent years [15].
Measuring resistance
Phenotypic susceptibility to the pyrethroid deltamethrin,
in the main local vector(s), was measured annually in
each cluster using WHO adult susceptibility tests and
recorded as percent mortality [19]. In Benin, Cameroon,
Kenya and Sudan larvae were collected from breeding
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sites within each cluster annually and reared to adult-
hood in insectaries. In India, where larval sites were
difficult to locate, resting females were caught [19].
Adult female mosquitoes [of unknown age (India); 2–5
days-old (all other countries)] were exposed for 60
minutes to deltamethrin using WHO impregnated
papers at standard concentrations (0.05% deltamethrin).
Mosquitoes were kept at temperatures between 23 and
27 °C, with humidity, where measured, between 75–85%.
Mortality was measured 24 h post-exposure. In all tests,
observed mortality in control mosquitoes was less than
5% therefore Abbott’s correction was not applied.
Statistical analysis
Mosquito mortality data were analysed at the level of the
individual mosquito, with post-exposure status (dead/alive
after 24 h) modelled as the response variable in logistic re-
gression. Explanatory variables of interest were year, years
since last LLIN distribution, and cluster- and year-specific
LLIN use as measured in cross-sectional household sur-
veys. Susceptibility test data were excluded from the
analysis if fewer than 40 mosquitoes were tested. A mortal-
ity estimate was calculated per cluster for each time point,
with data for each country analysed separately and in an
all-country model. Association between cluster mortality
estimates was assessed between years using binomial gener-
alised linear models. Separate generalised mixed-effect
models were used to assess trends in mortality over time,
effect of time since LLIN mass distribution and effect of
bednet use, with the cluster specified as the random effect
to account for within cluster correlation of responses. Year
was modelled as a linear term to investigate trends over
time. Where appropriate, a regional identifier was included
as a fixed effect to allow for spatial differences in resistance
within countries. Where data were available, insectary
temperature and humidity during resistance testing were
included in country-level models (Cameroon, India,
Sudan).
Cluster-level net usage, as a categorical variable (low,
< 40%; medium, 40–80%; and high, > 80%), was explored
as an explanatory variable in the years where these data
were available from concurrent cross-sectional surveys.
Table 1 Details of study sampling and sites including vector control coverage and insecticide resistance prevalence at baseline
Study sampling sites
Benin Cameroon India Kenya Sudan
Malaria
transmission
intensity
High High Low High Low
Study
locations
Districts of Ifangni,
Sakété, Pobé and
Kétou (Departement
de Plateau)
Districts of Garoua,
Pitoa and Mayo
Oulo (North region)
Subdistrict of
Keshkal (Kondagaon,
Chhattisgarh)
Districts of Teso,
Rachuonyo,
Nyando and Bondo
(western Kenya)
El Hoosh and Hag Abdalla
(Gezira State); Galabat
(Gedarif State; New Halfa
(Kassala State)
Number of
clusters sampled
32 38 80 61 79
Entomological
sampling points
(years)
2011–2015 2012–2015 2013–2016 2011–2015 2011–2014
Main malaria
vectors
Anopheles gambiae
(s.s.)a, Anopheles
coluzziia
An. arabiensisa, An.
gambiae (s.s.)a, An.
funestus
An. culicfaciesa An. gambiae (s.s.)a,
An. arabiensisa, An.
funestus
An. arabiensisa
Vector control
interventions
High coverage of
ITNs (primarily
PermaNet 2.0) in
all clusters
High coverage of
ITNs (PermaNet 2.0)
in all clusters
High coverage of
ITNs (PermaNet 2.0)
in all clusters
High coverage of ITNs
(PermaNet 2.0 and
Olyset Net) in all
clusters. Rachuonyo
and Nyando
received IRS with
deltamethrin and
lambda-cyhalothrin
in 2012, but no IRS
was carried out
subsequently
High coverage of ITNs
(PermaNet 2.0) in all
study clusters. In each
study area half of clusters
randomly allocated to
receive additional IRS
with bendiocarb
Baseline insecticide
resistance information
(cluster-specific range)
Kdr frequency by
cluster ranged from
44 to 93% (2011) WHO
Bioassay mortality to
deltamethrin ranged
between 20–100%
(2011)
Kdr frequency by
cluster ranged from
9 to 65% (2011) WHO
Bioassay mortality to
deltamethrin ranged
between 43–100% (2012)
WHO Bioassay
mortality to
deltamethrin
ranged between
86–100%
WHO Bioassay mortality
to deltamethrin ranged
between 1–100% (2011)
Kdr frequency by cluster
ranged from 8.3 to 70.8%
(2010); WHO Bioassay
mortality to deltamethrin
in sentinel clusters ranged
between 47–100% (2011)
aMortality results presented for these species in the analyses
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As bednet usage was only available for some years, a
time variable was not included in these models. To in-
vestigate whether the impact of bednet distributions
waned over time, models using time since bednet distri-
bution (in years) as the key explanatory variable (as op-
posed to calendar time) were also examined.
Data from all 5 countries were combined to investigate
whether there was evidence for an overall temporal
trend in phenotypic resistance, with country added as a
fixed effect. As the only data available from 2016 were
from India, the all-country analysis was undertaken with
and without India.
Results are presented in terms of changes in mortality
of mosquitoes by year [Odds Ratios (OR) per year] or
with increasing cluster-level category of net usage, with
a reduction in mortality indicative of increasing resist-
ance frequency.
Results
Estimates of mortality
More than 90,000 mosquitoes were tested in 911 separate
tests across 5 countries and over 6 years. The median num-
ber of mosquitoes exposed per cluster per year was 100
[interquartile range (IQR) 84–104]. Median mortality
across all tests was 81% (IQR: 63–94%). Insecticide resist-
ance, classified according to the WHO criteria of < 90%
mortality, was detected in all tested species, in all five coun-
tries and in 87% (n = 793) of tests performed. In only 7% of
tests performed (n = 63, from 57 clusters) was 100% mor-
tality observed. There were noticeable differences in the
proportions of clusters defined as susceptible across coun-
tries. For example, in India, ≥ 98% mortality was observed
in 28% (n = 66) of tests compared to only 1% of tests
(n = 2) in Sudan. In Benin, Cameroon, Kenya and Sudan,
> 50% mortality was recorded in at least 14% of tests
recorded; no tests in India had less than 50% mortality.
Temporal and spatial variation
Cluster-specific mosquito mortality showed limited and in-
consistent evidence of year-to-year correlation in all coun-
tries (Fig. 1). The strongest association was seen between
data points from 2014 and 2015 (Kendall’s tau coefficient:
0.42, P < 0.001), although this pattern differed by country,
with no correlation seen between those years in Benin or
India (Sudan ceased data collection in 2014) (Kendall’s tau
coefficient 0.07, P = 0.677, and 0.02, P = 0.886, respectively).
The strongest correlation between years was seen in
Cameroon, with Kendall’s tau coefficient > 0.3 for all year
pairs (P < 0.02), whilst for the other countries correlation
was only present in some pairwise comparisons.
Trends in mortality over time
The trends in mortality over the study period differed by
country (Table 2, Fig. 2). A decrease in mortality was
detected in Benin, Cameroon, Kenya and Sudan. A slight
increase in mortality was detected in India [aOR: 1.03
(95% CI: 0.98–1.1), P = 0.08]. The most substantial
yearly decrease was detected in Sudan [aOR: 0.67 (95%
CI: 0.64–0.70), P < 0.001]. With data from all countries
combined, a 21% decrease per year in odds of mortality
was detected [aOR 0.79 (95% CI: 0.79–0.81), P < 0.001].
This was not substantially altered with the exclusion of
India [aOR 0.77 (95% CI: 0.76–0.79), P < 0.001].
Effect of bednet distributions and bednet use
Bednet distributions occurred in all sites during the study
period. Associations between bednet usage and cluster
specific mosquito mortality was investigated for each year
that epidemiological cross-sectional data were available.
Mean net use was above 65% in all countries, with Kenya
reporting the highest value (94.2%). Benin, India and
Kenya had no clusters with less than 40% net usage. Net
usage appeared to have differential impact on mosquito
mortality in each country with no association found in
Benin and Kenya (P = 0.225 and P = 0.241, respectively);
higher mortality found in areas with higher net usage in
Cameroon (aOR 1.6 and 1.4 for net usage between 40–
80% and above 80% respectively, compared to clusters
with net use under 40%, P < 0.001) and strong negative as-
sociations found in India and Sudan (Table 3).
Time since bednet distribution was also investigated to
establish whether changes associated with bednet distri-
butions waned over time. Differential trends were evi-
dent with Benin, India and Sudan demonstrating an
increase in odds of mortality (decreasing resistance
frequency) for each year post-distribution (P < 0.001 for
each) whereas mosquito mortality in Cameroon (aOR:
0.95, P = 0.016) and Kenya (aOR: 0.59; P < 0.001) de-
creased (increased resistance frequency) with each year
post-LLIN distribution (Table 4).
Discussion
Insecticides have been a key component in the public
health and agriculture toolbox for over a century, result-
ing in the inevitable emergence of resistance in mosquito
vectors. This study brings together a very large collec-
tion of data from a range of transmission settings to in-
vestigate the trends in pyrethroid resistance. Whilst year
to year variation was substantial, and poor inter-year
correlation prevented cluster specific predictions of re-
sistance, a decrease in mosquito mortality was detected
in four out of the five countries over the 5-year period
of the study suggesting that resistance to pyrethroids has
been gradually increasing in these settings.
WHO encourages regular monitoring of resistance fre-
quencies to all insecticides used in country. Conse-
quently, the level of reporting has increased dramatically
in recent years with over 30,000 data points now entered
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Fig. 1 Association in cluster mortality between years. Scatter diagrams show results for clusters with mortality estimates in consecutive years for each
year of the study. The predicted mortality result from binomial generalised linear models is overlaid on each graph with 95% confidence intervals
Table 2 Impact of time on mosquito mortality. Results from generalised linear mixed-effect models examining the impact on
mosquito mortality over time (year)
Country Odds ratio for change in mortality per year (95% CI) P-value
All five countries combineda 0.79 (0.79–0.81) <0.001
Four countries combined (without India)a 0.77 (0.76–0.79) <0.001
Beninb 0.74 (0.72–0.76) <0.001
Cameroonc 0.74 (0.69–0.78) <0.001
Indiac 1.03 (0.98–1.10) 0.08
Kenyab 0.88 (0.86–0.90) <0.001
Sudanc 0.67 (0.64–0.70) <0.001
aAdjusted for country
bAdjusted for district
cAdjusted for district, temperature and humidity
Results are presented in terms of change in odds of mortality of mosquitoes in WHO bioassays by year. Odds ratios are adjusted for locality and temperature and
humidity where indicated. The data are shown for each country, as well as all countries combined (with country included as a covariate). Cluster was included as a
random effect in all models
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Fig. 2 Box-and-whisker plots showing the range of cluster-level mortality by year and country. Arrows indicate the timing of bednet distributions
within country
Table 3 Impact of cluster-level bednet usage on mosquito mortality. Results from generalised mixed-effect models examining the
impact of cluster-level bednet usage on mosquito mortality
All countries combineda Beninb Cameroonc Indiac Kenyab Sudanc
No. of clusters
included (year)
59 (2012); 87 (2013); 143
(2014); 99 (2015); 80 (2016)
19
(2015)
22 (2013);
26 (2014)
80 (2015);
80 (2016)
13(2012);
41 (2014)
46 (2012); 65
(2013); 76 (2014)
Mean net usage
(range) (%)
74.9
(52.5–100)
67.8
(7.0–100)
89.9
(60.9–100)
94.2
(73.7–100)
78.6
(0–100)
Effect of cluster-level net
usage on mosquito mortality,
OR (95% CI)
< 40% 1 (reference) – 1 (reference) – – 1 (reference)
40–80% 1.03
(0.89–1.19)
1
(reference)
1.61
(1.21–2.14)
1
(reference)
1
(reference)
0.69
(0.58–0.83)
> 80% 0.65
(0.57–0.74)
1.59
(0.75–3.37)
1.40
(1.08–1.82)
0.36
(0.29–0.44)
2.38
(0.56–10.1)
0.45
(0.38–0.53)
P-value <0.001 0.225 <0.001 <0.001 0.241 <0.001
aAdjusted for country
aAdjusted for district
cAdjusted for district, temperature and humidity
Results are presented in terms of change in mortality of mosquitoes for increasing bednet usage category (< 40%; between 40–80%; and above 80%). Bednet
usage was calculated for years where cross-sectional survey data was available. Odds ratios are adjusted for locality and temperature and humidity where
indicated. The results are shown for each country, as well as all countries combined (with country included as a covariate). Cluster was included as a random
effect in all models
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into global databases such as the WHO Malaria Threats
Map [20] and IR-mapper (www.irmapper.com) [21]. The
picture that emerges from these summary data [6, 22,
23], as with the present study, is that resistance to pyre-
throids is increasing in frequency and geographic extent.
However, these global databases often aggregate data
with substantially differential sampling effort across
years and regions [6] which may obscure the substantial
stochasticity in mortality estimates.
It is assumed that the increase in resistance to pyre-
throids over the past decade is due in part to the higher
coverage of insecticide-based interventions, such as
LLINs. However, studies have shown conflicting results
with some reports of increasing resistance following bed-
net distributions [24–27], and other reports of no in-
creases despite sustained insecticidal campaigns [28–30].
Although ascertaining the effect of bednet coverage was
not a primary goal of this study, it was possible to inves-
tigate the impact of net use through cross-sectional sur-
veys that were conducted concurrently to resistance
measurements. Trends were not uniform across coun-
tries, perhaps in part reflecting the differing biology of
the vector species. Anopheles arabiensis (a major vector
in Kenya, Cameroon and Sudan study locations) and An.
culicifacies (primary vector in India study locations)
commonly show high rates of zoophily. Obtaining blood
meals from sources other than humans means LLINs
would potentially have less impact on selective pressure
for resistance. However, overall, higher net usage was as-
sociated with increasing resistance in mosquitoes. This
trend was most evident in Sudan where the widest range
of net usage was reported whereas in other settings re-
ported net usage was more uniform, thereby reducing
the likelihood of detecting a trend.
We did not discern a consistent trend in mosquito mor-
tality with increasing time post-net distribution. In Benin,
India and Sudan, mortality increased every year
post-distribution, suggesting that the initial increased
coverage of nets may have been a short-term driver for re-
sistance and that as the insecticide on the nets reduced
over time, the selection pressure reduced, in turn reducing
the proportion of resistant mosquitoes. However, in
Cameroon and Kenya, the opposite effect was observed,
with mortality decreasing with every year from the date of
the distribution. Data from the An. gambiae 1000 genome
project has revealed that there appear to be numerous in-
stances of localised adaptation to insecticide pressure [31].
The difference we observed in response to LLIN distribu-
tion may reflect in part this innate difference of vector
populations to respond to insecticide pressure and caution
against making generalised predictions.
Moreover, whilst bednet distributions will have in-
creased selection pressure in the study settings, it is also
possible that the insecticide resistance could be linked to
ongoing agricultural practices [32–34]. In several African
countries, including northern Cameroon, the use of py-
rethroids for cotton farming has been implicated as a
catalyst for the increase in recorded resistance in An.
gambiae populations [34–36]. Differences in the use of
pyrethroids for agricultural purposes in the study set-
tings could further impact the relationship between time
of net distribution and insecticide resistance.
Previous studies have also shown resistance to be
highly focal [16, 37–39], with large variations over
small geographical distances. This is exemplified by
the range of mortality measures within each country
and highlights the need for multiple sentinel monitor-
ing sites per country and reinforces that extrapolating
resistance data from few, widely-dispersed sentinel
sites to larger areas is untenable. Spatial heterogeneity
in insecticide resistance poses challenges for integrated
resistance management and suggests that locally tailored
vector control and resistance management programmes
are required.
There was considerable temporal heterogeneity with
high between year variation at cluster level. This
phenomenon has also been reported elsewhere [40–43].
There are several reasons why levels of resistance in a
mosquito population may fluctuate over time, for in-
stance, resistance can recede if proper resistance man-
agement practices are implemented or if resistance
drivers reduce and resistance associated genetic variants
are deleterious in the absence of selection pressure [5,
44]. It is possible that in our study settings varying ex-
posure to pyrethroids resulted in fluctuating frequency
of resistance in the mosquito population with evidence
from some areas suggesting that bednet usage resulted
in higher resistance frequencies.
Table 4 Impact of time since bednet distribution (years) on
mosquito mortality. Results from generalised mixed-effect
models examining the impact time since bednet distribution on
mosquito mortality
Country Odds ratio for change in
mortality per year (95% CI)
P-value
All countries combineda 1.34 (1.31–1.37) <0.001
Beninb 3.20 (3.02–3.39) <0.001
Cameroonc 0.95 (0.90–0.99) 0.016
Indiac 1.62 (1.52–1.73) <0.001
Kenyab 0.59 (0.56–0.62) <0.001
Sudanc 1.60 (1.53–1.67) <0.001
aAdjusted for country
bAdjusted for district
cAdjusted for district, temperature and humidity
Results are presented in terms of change in mortality of mosquitoes for each
year since a mass bednet distribution took place in-country. Odds ratios are
adjusted for locality and temperature and humidity where indicated. The
results are shown for each country, as well as all countries combined (with
country included as a covariate). Cluster was included as a random effect in
all models
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As well as genuine fluctuations in the frequency of
resistance, it is possible that the different susceptibil-
ity recorded is, in part, an artefact of the method of
testing. Longitudinal monitoring is easily influenced
by any changes in protocol for measuring mortality
and the timings of the tests. Some studies have dem-
onstrated fluctuations in mosquito mortality over a
transmission season [45] and whilst all efforts were
taken to ensure that tests occurred at the same time
each year, differences between seasons may have had
an impact. In addition, humidity and temperature are
known to have an impact on mortality testing [46];
whilst these were controlled for where data were
available, it is possible that differing conditions influ-
enced mortality results.
There is mounting evidence that tests recording mos-
quito mortality after 24 h may not be the best way to
record changes in population resistance, particularly
when the level of resistance is high [47]. A number of
alternative options are now available for monitoring the
presence of resistance, including molecular assays, time/
dose response assays and increasing the time
post-exposure at which mortality is calculated, all of
which are likely to be more sensitive to resistance trends
[48–51], but these methods are also more resource in-
tensive. Although as noted by Churcher et al. [4] the
strong association between bioassay data and mortality
measured in experimental hut trials still supports the
use of bioassays as a quantitative test of the impact of
resistance on LLIN efficacy. In this multi-country study,
to ensure comparability between sites, the test was per-
formed using one insecticide dose and one exposure
time, using wild-caught mosquitoes reared in the labora-
tory. These settings may not reflect adequately the con-
ditions wild mosquitoes experience, such as variations in
temperature, food availability and pre-existing pesticide
exposure [51]. In addition, the doses used in the resist-
ance tests are not necessarily reflective of the doses mos-
quitoes would experience in the wild, which can be
influenced by age or retreatment of ITN or regularity
and coverage of IRS. The dose used for detecting resist-
ance can have a particularly strong effect depending on
the prevalence and penetrance of the resistant mecha-
nisms present in the mosquito population. Recording
mortality at 24 h may also miss some of the nuances
involved with the evolution of resistance which may re-
sult in delayed mortality [51]. In addition, mosquito age
has been shown to have a big impact on susceptibility,
with older mosquitoes showing higher mortality rates
compared to their younger counterparts [52]. If insecti-
cides remain effective against mosquitoes old enough to
transmit malaria, this may explain why some studies are
observing minimal impact on epidemiological outcomes
[10–12, 14].
Conclusions
This study demonstrated increasing frequency of resist-
ance to pyrethroids in malaria vectors from 4 out of 5
study countries. Although the increase does not appear
linear, if the current trend continues, it is likely to result
in a reduction of the effectiveness of pyrethroid-based
interventions such as ITN and IRS. There was evidence
in some countries of increased selection pressure for
pyrethroid resistance in clusters where net use was
higher. There are a number of strategies presented
within GPIRM to mitigate the increase of insecticide re-
sistance in malaria vectors such as rotations, combina-
tions, mosaics and mixtures [5]. In the short term, two
trials have demonstrated improved efficacy of
dual-active [53] and pyrethroid-PBO treated LLINs [54],
suggesting that we are likely to be able to prolong the
useful active life of pyrethroid-based interventions. How-
ever, the lack of vector control tools with different
modes of actions and their increased costs, means that
many endemic countries will continue to struggle to de-
velop and implement insecticide resistance management
plans. Whilst new products are currently being trialled
[55–57], and some have recently come to market, the
fine-scale monitoring of resistance phenotypes and
mechanisms will be key to mitigating the impacts of in-
secticide resistance through informed selection of vector
control tools.
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